Clinical study evaluates the safety and efficacy of the OA Kneetrac CHANGEUI MEDICAL co., Ltd. for patients with knee joint osteoarthritis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002179

Enrollment

Registered

2016-12-23

Start date

2016-06-30

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : - control group: therapeutic exercise, Two or more times a day, 7days per weeks, totally 6weeks - experimental group: therapeutic exercise, Two or more times a day, 7days per weeks, t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adults over 20 years old 2) Diagnosis: Osteoarthritis of the Knee 3) In the anteroposterior x-ray of the knee in a standing position according to the scale Kellgren-Lawrence (K-L) patient received ?, ? grade diagnosis 4) The patient has subscribed the informed consent

Exclusion criteria

Exclusion criteria: 1) The patients with lower extremity surgical treatments and cortisone injections for those who receive treatment within the last 3 months. (Steroidal and non-steroidal anti-inflammatory drug treatments, such as drugs does not limit) 2) The patients with ligaments injury, knee joint infection, inflammatory joint disease, fibromyalgia, symptoms of nerve root compression in the spine, central nervous system diseases, polyneuropathy, cognitive disorders, etc. 3) Principal investigator who is deemed unsuitable for clinical trial participation

Design outcomes

Primary

Measure	Time frame
WOMAC score(Western Ontario and McMaster Universities Arthritis Index)	—

Secondary

Measure	Time frame
Quality of Life SF-36(Short Form-36);VAS(Visual Analog Scale);Bio-dex	—

Countries

Korea, Republic of

Contacts

Public ContactLEE YEON

Chonbuk National University Hospital

sylee@mdctc.or.kr+82-63-259-3459

Outcome results